Although MG is an autoimmune pathology that targets the peripheral nervous system and not the CNS, it is noteworthy that a research group reported a significant increase in IL-19 and IL-20 serum levels similar to other well characterized pro-inflammatory cytokines that impact CNS (Uzawa et al., 2016). Here, IL19 is linked to myasthenia gravis.